Biotech Leaders Ponder Tariff Ramifications

 
• By Joseph Haas, Mary Jo Laffler, and Jessica Merrill
  
Potential US tariffs' impact on pharmaceuticals has biotechs considering their options (Shutterstock)

More from Financing

More from Supply Chain